Results 21 to 30 of about 14,442 (179)

Using Real-Time RT-PCR Reagent Kits for Identity Testing of Measles, Mumps and Rubella Vaccines

Биопрепараты: Профилактика, диагностика, лечение, 2018
Currently, the identity of measles, mumps and rubella virus vaccines is determined during certification testing by a labour-consuming, lengthy and costly neutralisation test using cell cultures.
A. S. Binyatova, E. D. Mytsa, N. V. Chertova, R. A. Volkova, K. A. Sarkisyan, T. N. Ilyasova, T. N. Yunasova, A. A. Movsesyants, V. A. Merkulov   +8 more
doaj   +1 more source

Comparative long-term follow-up study of persistence of immunity after JVC-001 measles, mumps, and rubella vaccination in Japanese children

Human Vaccines & Immunotherapeutics
JVC-001 is a novel measles-mumps-rubella (MMR) combined vaccine. In the J301 clinical trial, healthy 1-y-old Japanese children received either JVC-001 or marketed measles-rubella (MR) and mumps vaccines as control group.
Tetsuo Nakayama, Keiji Oe, Takafumi Nakatsu, Yoshitaka Sogawa, Tadaaki Ioroi, Shizuo Shindo   +5 more
doaj   +1 more source

Immunological Protection Against Vaccine-Preventable Infections (Hepatitis B, Measles, Rubella, Mumps, Diphtheria, Tetanus) of Russian and Foreign Students: A Simultaneous Study

Педиатрическая фармакология, 2020
The increase in the incidence of vaccine-preventable infections is due to the low level of immunological protection of the population, which against the background of active migration processes can determine high risks of outbreaks of infectious diseases
Diana V. Sutovskaya, Alla V. Burlutskaya, Larisa V. Dubova, Daria R. Krylova, Olga G. Korobkina   +4 more
doaj   +1 more source

Immunogenicity and safety of the new MMR vaccine containing measles AIK-C, rubella Takahashi, and mumps RIT4385 strains in Japanese children: a randomized phase I/II clinical trial

Human Vaccines & Immunotherapeutics, 2019
Domestic measles, mumps, and rubella combined (MMR) vaccines were discontinued in 1993 in Japan because of the unexpected high incidence of aseptic meningitis. The introduction of an effective MMR vaccine with lower reactogenicity has been expected.
Tetsuo Nakayama, Masahiro Eda, Motonori Hirano, Wakako Goto   +3 more
doaj   +1 more source

Varicella vaccines and measles, mumps, rubella, and varicella vaccine

Jornal de Pediatria, 2006
To present an up-to-date review of studies investigating the efficacy, adverse events and vaccination regimens of the varicella vaccine and the new presentation combined with the vaccine for measles, mumps and rubella.Bibliographic review of the MEDLINE and LILACS databases covering the period 1999 to 2006.The varicella vaccine protects 70 to 90% of ...
Lucia Ferro, Bricks, Helena Keico, Sato, Gabriel Wolf, Oselka   +2 more
openaire   +2 more sources

Herd immunity to measles, rubella, and mumps in several Russian regions

Инфекция и иммунитет
Introduction. Mass vaccination, implemented in Russia within the framework of the Russia National Vaccination Calendar, is a key component in the fight against vaccine-preventable infections (measles, mumps, rubella). The aim.
Anna Yu. Popova, Vyacheslav S. Smirnov, Svetlana A. Egorova, Lidiya V. Buts, Angelika M. Milichkina, Valery A. Ivanov, Ekatherina M. Danilova, Oyuna B. Zhimbaeva, Victoria G. Drobyshevskaya, Oleg V. Kotsar, Olga P. Kurganova, Natalia A. Penkovskaya, Elena A. Babura, Natalya E. Potalitsina, Sergey V. Balakhonov, Natalya A. Sadykova, Natalya N. Zaytseva, Ekaterina N. Burdinskaya, Yulia A. Natykan, Svetlana A. Listopad, Liliya V. Mironova, Valentina I. Dubrovina, Anastasia V. Polyanina, Anna D. Kashnikova, Olga I. Deryabina, Margarita D. Senina, Nadezhda A. Likhanova, Nikolai G. Usovik, Natalya A. Berkovich, Zhanna R. Molchanova, Elena A. Kudryashova, Tatyana V. Arbuzova, Daria A. Starkova, Alena V. Svarval, Lyudmila V. Suzhaeva, Kristina A. Frolova, Areg A. Totolian   +36 more
doaj   +1 more source

Measles Vaccination Before the Measles-Mumps-Rubella Vaccine

American Journal of Public Health, 2013
At the beginning of the 1960s, it was clear that a vaccine against measles would soon be available. Although measles was (and remains) a killer disease in the developing world, in the United States and Western Europe this was no longer so. Many parents and many medical practitioners considered measles an inevitable stage of a child’s development ...
Jan, Hendriks, Stuart, Blume
openaire   +3 more sources

The efficacy of 20% salicylic acid solution versus intralesional MMR vaccine combination with 20% salicylic acid solution in treatment of plane wart

Advanced Medical Journal
Background and objectives: Plane wart treatment is challenging; modalities such as cauterization and cryotherapy having a great probability to recur, as well as the risk of scarring, discomfort, and expensive costs.
Banu Muhammed Jaza Noori, Ali Mozan Dhahir Elethawi   +1 more
doaj   +1 more source

Immunogenicity and Safety of a Novel MMR Vaccine (Live) (Freeze-dried): Results of a Phase II Clinical Trial [PDF]

Journal of Clinical and Diagnostic Research, 2018
Introduction: This is the first study in Indian paediatric subjects to evaluate the novel Measles, Mumps and Rubella (MMR) vaccine developed by M/s Cadila Healthcare Limited, India, containing the Hoshino mumps strain.
Rajesh Joshi, Neeta Hanumante, Uma Nayak, Shalaka Agarkhedkar, Paresh Thakkar, Jayesh Sanmukhani, Ravindra Mittal   +6 more
doaj   +1 more source

Diagnosis and management guidelines for infantile epileptic spasms syndrome around the world: A scoping review and comparative study of international approaches

Epilepsia, EarlyView.
Abstract Objective Infantile epileptic spasms syndrome (IESS) is an epileptic encephalopathy requiring rapid diagnosis and treatment to optimize neurodevelopmental outcomes. Although multiple national and regional guidelines exist, recommendations vary.
Gozde Erdemir, Chethan K. Rao, Anne Francine Pino, Christina Briscoe, Debopam Samanta, Jo M. Wilmshurst, Sonal Bhatia, Jessica L. Carpenter, Christina Hoei‐Hansen, Puneet Jain, Tommy Stodberg, Robyn Whitney, Ryuki Matsuura, Karina Rosso Astorga, Keryma Acevedo Gallinato, Pratibha Singhi, Aristides Hadijinicolaou, Gia Melikishvili, Patricia Smeyers, Nicola Specchio, Stéphane Auvin, Pediatric Epilepsy Research Consortium Infantile Spasm Work Group and International Committee   +21 more
wiley   +1 more source